--- Page 1 ---
REVIEW
published:16July2018
doi:10.3389/fbioe.2018.00099
Blood-Contacting Biomaterials: In
Vitro Evaluation of the
Hemocompatibility
MarbodWeber,HeidrunSteinle,SoniaGolombek,LudmillaHann,ChristianSchlensak,
HansP.WendelandMeltemAvci-Adali*
DepartmentofThoracicandCardiovascularSurgery,UniversityHospitalTübingen,Tübingen,Germany
Hemocompatibilityofblood-contactingbiomaterialsisoneofthemostimportantcriteria
for their successful in vivo applicability. Thus, extensive in vitro analyses according to
ISO 10993-4 are required prior to clinical applications. In this review, we summarize
essentialaspectsregardingtheevaluationofthehemocompatibilityofbiomaterialsand
therequiredinvitroanalysesfordeterminingthebloodcompatibility.Static,agitated,or
shearflowmodelsareusedtoperformhemocompatibilitystudies.Beforeandafterthe
incubation of the test material with fresh human blood, hemolysis, cell counts, and the
activation of platelets, leukocytes, coagulation and complement system are analyzed.
Furthermore,thesurfaceofbiomaterialsareevaluatedconcerningattachmentofblood
Editedby:
cells,adsorptionofproteins,andgenerationofthrombusandfibrinnetworks.
NihalEnginVrana,
ProtipMedical,France
Keywords:hemocompatibility,bloodcontact,biomaterials,coagulation,complementsystem
Reviewedby:
GiovannVozzi,
UniversitàdegliStudidiPisa,Italy INTRODUCTION
ElifVardar,
CentreHospitalierUniversitaire
Hemocompatibility is one of the major criteria, which limit the clinical applicability of blood-
Vaudois(CHUV),Switzerland
contacting biomaterials. These materials come in close contact with blood, which is a complex
*Correspondence: “organ,” comprising of 55% plasma, 44% erythrocytes, and 1% leukocytes and platelets. Thus,
MeltemAvci-Adali
adverseinteractionsbetweennewlydevelopedmaterialsandbloodshouldbeextensivelyanalyzed
meltem.avci-adali@uni-tuebingen.de
topreventactivationanddestructionofbloodcomponents.Theinitiallyadsorbedproteinlayeron
thebiomaterialsurfacemainlytriggerstheadversereactions,suchastheactivationofcoagulation
Specialtysection:
viaintrinsicpathway,theactivationofleukocytes,whichresultsininflammation,andtheadhesion
Thisarticlewassubmittedto
Biomaterials, andactivationofplatelets(Liuetal.,2014).Asaresult,thenumberofbloodcellscandecreaseand
asectionofthejournal athrombuscanbeformed.
FrontiersinBioengineeringand Thus,theappliedblood-contactingbiomaterialsshouldnotadverselyinteractwithanyblood
Biotechnology components and activate or destruct blood components. Erythrocytes are the most abundant
Received:12May2018 bloodcellswith4–6×106 cells/µlandtheyareimportantforthetransportofoxygen(O 2 )from
Accepted:26June2018 the lung to all tissues and cells and carbon dioxide (CO ) from tissues back to the lung. Since
2
Published:16July2018 erythrocytes are the most rigid cells in the blood, they are sensitive to rupture and hemolysis
Citation: due to shear stress and changes in osmotic pressure. Blood platelets are the smallest (1–3µm)
WeberM,SteinleH,GolombekS, and the second abundant cell type in the blood with 1.5–3.5 × 105 cells/µl, which can rapidly
HannL,SchlensakC,WendelHPand recognize foreign surfaces and initiate blood coagulation. Furthermore, human blood contains
Avci-AdaliM(2018)Blood-Contacting 4.3–10×103 leukocytes/µl,suchasgranulocytes,lymphocytes,monocytes,dendriticandnatural
Biomaterials:InVitroEvaluationofthe
killercells.Monocytesaccountfor1–6%ofallleukocytesandneutrophilgranulocytesarethemost
Hemocompatibility.
Front.Bioeng.Biotechnol.6:99. abundantleukocytesintheblood,comprising50–70%ofallleukocytes.Theseimmunecellsare
doi:10.3389/fbioe.2018.00099 belonging to the innate immune system and they can be rapidly activated upon recognition of
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 1 July2018|Volume6|Article99

--- Page 2 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
a foreign invader such as a pathogen or a foreign material.
Furthermore, blood plasma contains high amounts of
plasma proteins, such as albumin, coagulation factors, and
immunoglobulins.
Catheters,guidewires,dialyzer,oxygenators(artificiallungs),
heart-supporting systems, cardiac pacemaker, vascular grafts,
stents, heart valves, micro-, and nanoparticles are widely used
medical devices and materials coming in direct contact with
blood. Prior to clinical application, the hemocompatibility
of blood-contacting medical materials have to be analyzed
and therefore, a guidance is developed by the International
Organization for Standardization (ISO 10993-4) (International
Organization for Standardization, 2000). According this
guideline, five different categories, thrombosis, coagulation,
platelets, hematology, and immunology (complement system
andleukocytes),areindicatedforhemocompatibilityevaluation.
The devices are divided into three categories concerning blood
contact: (1) Externally communicating devices with indirect
blood contact, e.g., cannulas and blood collection sets; (2)
Externally communicating devices with direct blood contact,
e.g.,cathetersandhemodialysisequipment;(3)Implantdevices,
e.g.,heartvalves,stents,andvasculargrafts.Sofar,severalstudies
were performed according ISO-10993-4 to evaluate various
blood contacting devices and materials, such as stents (Sinn
etal.,2011;Stangetal.,2014),catheterswithanoblemetalalloy
coating (Vafa Homann et al., 2016), poly(2-dimethylamino- FIGURE1|Schematicrepresentationoftheprocedurefortheevaluationof
ethylmethacrylate) (PDMAEMA) (Cerda-Cristerna et al., thehemocompatibilityofbiomaterials.First,freshhumanbloodiscollected
2011), and DNA hydrogels (Stoll et al., 2017). To perform andanticoagulatedwithlowdoseheparin.Thereafter,thetestmaterialis
incubatedat37◦Cusingstatic,agitated,ordynamictestmodelswiththe
hemocompatibilityanalysis,static,agitated,orshearflowinvitro
blood.Theactivationmarkersinthebloodareanalyzedbeforeandafterthe
modelsareusedfortheincubationofbloodwiththebiomaterial. incubationwiththetestmaterial.Furthermore,thesurfaceofthebiomaterialis
Beforeandaftertheincubationofbiomaterialswithfreshhuman analyzedtodeterminetheinteractionofbloodcellsandproteinswiththe
blood, the activation markers regarding hemocompatibility are biomaterialsurface.
analyzed(Figure1).
should be performed with fresh blood from healthy subjects
INCUBATION OF BIOMATERIALS WITH (Blok et al., 2016). Blok et al. demonstrated that the stationary
HUMAN BLOOD storageofbloodover4hatroomtemperatureaffectstheplatelet
functionandactivityofleukocytes.Thus,experimentsshouldbe
Using fresh human blood and adequate in vitro models, the startedwithin4hafterthebloodcollection.However,thefaster
hemocompatibility of blood-contacting biomaterials can be the experiments are started, the better it is. Peripheral blood
studiedaccurately.Comparedtoinvivoanimalmodels,invitro should be collected from healthy non-smoker, non-pregnant
models allow the analysis under well controllable conditions subjects free of medication (particularly drugs affecting the
such as blood flow, anticoagulation and eliminate disturbing hemostasis,suchasaspirin,oralcontraceptives,andnonsteroidal
factors related to flow obstruction, surgery, and tissue effects anti-inflammatorydrugs).Moreover,atraumaticbloodcollection
(van Oeveren, 2013). Furthermore, the blood contact is more byminimizingvenostasisduringbloodwithdrawalandtheuseof
intense and products generated due to reaction of the blood 21-gaugeneedlesisrequired tominimizeactivationofplatelets
components to the biomaterial are not cleared. Moreover, and the coagulation cascade during collection (Braune et al.,
using in vitro models, different devices can be analyzed under 2013).
the same conditions, which enable the direct comparison Furthermore, prior to starting hemocompatibility analyses,
of outcomes. Thereby, positive controls, which show a poor unreacted monomers, intermediate- or by-products, solvents,
hemocompatibility, such as glass (Ferrer et al., 2013), devices and unwanted chemical residues should be removed by
or biomaterials, which are already on the market with a appropriate washing and cleaning procedures from generated
comparable surface area, and negative controls without test biomaterials to eliminate an unwanted influence on blood
material should be simultaneously tested to be able to evaluate components.Dependingonbiomaterial,device,andproduction
thehemocompatibility. technique, different washing and cleaning procedures with
Thequalityofcollectedbloodisextremelyimportanttoenable different solutions are required, for example ethanol can be
standardized hemocompatibility analysis. The in vitro analysis removed by evaporation or washing with PBS (Punet et al.,
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 2 July2018|Volume6|Article99

--- Page 3 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
2015), NaCl, or water and unreacted methacrylic anhydride blood with air bubble to allow the blood mixture and rotated
◦
and by-products can be eliminated by dialysis (Xiao et al., in a water bath with 37 C to stimulate blood circulation. In
2011;Camci-Unaletal.,2013).Additionally,endotoxincontent modified versions of the Chandler loop, small materials, such
shouldbedeterminedtoexcludematerial-unrelatedactivationof as stents are inserted in tubings and then filled with blood
plateletsandbloodcellsduetopresenceofendotoxins(Watanabe (Müller et al., 2012). Since the Chandler loop is partially filled
et al., 2003; Kälsch et al., 2007; Schrottmaier et al., 2016). with air, the device circulates through an air-liquid interface.
Furthermore,aprocesscalleddepyrogenationcanbeappliedto Thus, this method can lead to the denaturation of proteins at
remove endotoxins from biomaterials (Li and Boraschi, 2016). the air-liquid interface (Thorsen et al., 1993;Ritz-Timme et al.,
For example by using detergents (e.g., Triton X-114) and a 1997) and the detachment of adhered blood cells. Therefore,
two-phase extraction method, endotoxins can be eliminated roller pump closed-loop test systems were also used instead
(Zhang et al., 2015). After the addition of the detergent to the of Chandler loop. Hereby, the blood flow is realized by using
sample,endotoxinsareincorporatedintomicellesvianon-polar a pump. However, due to use of a pump even with lowest
interactionsofthesurfactantendgroupsandalkylchainsoflipid pumping rates a slight destruction of erythrocytes (hemolysis)
A, which is the most conserved part of endotoxins (Magalhães canoccur.VanOeverenandcolleaguesanalyzedadditionallyto
etal.,2007).Theincreaseoftemperatureleadstotheformationof theChandlerloopandrollerpumpmodel,theHemobilemodel
awaterphase(micelle-poor)andamicelle-richphase.Thereby, (Van Oeveren et al., 2012) regarding intrinsic damage of blood
endotoxins remained in the micelle-rich phase (bottom-phase) components and activation of platelets. Hemobile model has a
canberemoved. one-wayballvalvetoensureunidirectionalflowandthetubing
containsnoair,andthereisnomechanicaldevicecompressing
Static Blood Incubation Models the tubing. Thus, using this model, less blood trauma
In static blood incubation models, test materials are incubated was induced compared to Chandler-Loop and roller pump
withbloodorplatelet-richplasma(PRP)withoutflowconditions model.
(Mohan et al., 2013). Therefore, container, such as well However, the main limitation of these in vitro models is
plates or tubes, can be used to incubate the material with a the lack of an endothelium in the circulating system. The
certain blood or PRP volume. It is a very simple and rapid endothelium produces cytokines, anti-thrombotic components
method to determine the hemocompatibility of biomaterials, andexpressesadhesionmoleculesforthrombocytes,monocytes,
especially the thrombogenicity. However, this method provides and neutrophils and plays an important role in interaction
onlyrudimentaryresultsregardinghemocompatibility.Thereby, betweenthecirculatingbloodandinjuredvesselwall.Therefore,
majorlimitationscanbethecellsedimentationandthebigblood- inarecentstudy,Nordlingetal.usedanovelbloodendothelial
airinterface,whichcanleadtoaproteinaggregationandresult cell chamber model to study the interactions between human
inplateletactivation(HaycoxandRatner,1993). whole blood and endothelium (Nordling et al., 2014). There,
the blood contacting surface of incubation chambers were
Agitated Blood Incubation Models seededwithhumanumbilicalveinendothelialcells(HUVECs).
In agitated blood incubation models, flat incubation chambers Furthermore,arelativelynewfieldfortheexaminationofplatelet
with top and bottom surfaces made of the test material are andcoagulationactivationistheuseofmicrofluidics(Kentetal.,
completely filled with blood and incubated on a shaker or 2010;Onasoga-Jarvisetal.,2013,2014;Kovachetal.,2014;Zhu
overhead rotator without directed flow (Streller et al., 2003). et al., 2015; Nagy et al., 2017). Using microfluidic flow devices
Furthermore,thecontainerfilledwiththebloodcanberotated plateletandcoagulationactivationcanbedeterminedatthesame
to prevent the sedimentation of the test material, such as timeandunderdefined,physiologicalorpathological(stenotic)
nanoparticles(Maitzetal.,2017).Usingthesemodels,theblood- wall shear rates. Due to the small size of microfluidic devices,
aircontactisalmostexcludedandcellsedimentationisreduced. only small amounts of blood are required. Furthermore, the
combinationwithfluorescencemicroscopyallowsthereal-time
Shear Flow Models opticalimagingofplateletadhesionandformationoffibrinfibers
Flat-plate flow chambers (Van Kruchten et al., 2012), parallel- (Westeinetal.,2012;Zhuetal.,2015).
plate and cone-platelet viscometer (Lackner et al., 2012), and
tubular systems such as the “Chandler loop” (McClung et al.,
2007; Krajewski et al., 2013; Stang et al., 2014) and the roller ANALYSIS OF HEMOCOMPATIBILITY
pumpclosed-loop(Podiasetal.,1995;Wangetal.,2001)systems
aresomeofinvitroshearflowmodels.Inthesemodels,vascular Using the described in vitro models, various information
blood flow is mimicked to simulate the dynamic interaction regarding hemocompatibility (Figure2) can be obtained: (1)
betweenthebiomaterialandwholeblood(SanakandWegrzyn, Changesofplatelets,erythrocytesandleukocytes,(2)Generation
2010).In flat-plateflow chambers,blood flows over a flatpiece of activation products in plasma, (3) Deposition of proteins
of biomaterial and in parallel-plate viscometers, blood is filled and cells on the material surface. Thus, blood and surface of
betweentwoplatesmadeofthebiomaterialtobetestedandone biomaterials are analyzed before and after the incubation. In
oftheplatesisrotatedrelativetotheother(Sukavaneshvar,2017). Table1, test categories for the hemocompatibility analysis of
In Chandler loop, a circular conduit made of the biomaterial biomaterialsaresummarizedandinthefollowing,therequired
or coated with the biomaterial, is filled with fresh human analysesfortheevaluationofhemocompatibilityaredescribed.
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 3 July2018|Volume6|Article99

--- Page 4 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
FIGURE2|Schematicrepresentationofmajorreactionsinbloodinducedbybiomaterialsurface.Besidescomplementsystem,intrinsicandextrinsiccoagulation
pathwaycanbeactivated.Coagulationactivationresultsingenerationofafibrinnetwork.Furthermore,plateletscanadhereandaggregateonthesurface.The
adhesionandactivationofleukocytescanleadtothereleaseofpolymorphonuclear(PMN)elastaseandtissuefactor(TF)andresultinactivationofextrinsicpathway.
ADP,Adenosinediphosphate;β-TG,β-Thromboglobulin;GPIIb/IIIa,GlycoproteinIIb/IIIa;MAC,Membraneattackcomplex;PF4,Plateletfactor4;TXA2,Thromboxane
A2;vWF,vonWillebrandfactor.
DETERMINATION OF BLOOD CELL hemoglobin to the cyanoderivate (Neun and Dobrovolskaia,
NUMBERS AND HEMOLYSIS 2011). The absorption of CMH is measured at 540nm using a
photometer.Dependingonhemolysis,materialscanbeclassified
The number of erythrocytes, leukocytes, and platelets is in three different categories: Materials resulting in over 5%
measured before and after the incubation of blood with hemolysisareclassifiedhemolytic,between5and2%asslightly
biomaterial using a hematology analyzer, which uses electrical hemolytic,andbelow2%asnonhemolytic(Toteaetal.,2014).
impedance. A decrease of the platelet count over time
indicatesathrombogenicmaterial.Furthermore,theruptureof
COAGULATION ACTIVATION
erythrocytes, called hemolysis, is accompanied by the release
of hemoglobin. Thus, an increased concentration of free
Theinteractionofplasmaproteinswithartificialsurfacestriggers
hemoglobin in the plasma is a direct indicator of erythrocytes
intrinsiccoagulationpathwaybycontactactivation.Thecontact-
destruction.Thedamageoferythrocytescanleadtothereduced
phase system consists of three serine proteinases, factor XII,
oxygen transport to tissues and organs in vivo and increased
factorXI,andplasmaprekallikrein(PK),andthenonenzymatic
levelsoffreehemoglobincaninducetoxicityoralterthekidney
cofactor high molecular weight kininogen (HMWK) and it is
function(Qianetal.,2010).Additionally,microvesiclesderived
also called as plasma kallikrein-kinin system (Wu, 2015). The
from erythrocytes can promote the thrombus formation in a
contact of blood with artificial, negatively charged surfaces,
tissue factor (TF)-dependent manner (Biró et al., 2003). Thus,
such as kaolin, glass, collagen, silica, or dextran sulfate, leads
hemolysiscanbeanalyzedafterdirectorindirectbloodcontact.
to the conversion of Factor XII to the active enzyme Factor
In direct analysis, blood is incubated with the biomaterial and
XIIa.FactorXIIaconvertsPKintoactivekallikreinandHMWK
in indirect testing blood is incubated with biomaterial extract
into bradykinin. Besides coagulation, kallikrein and bradykinin
(Kuhbier et al., 2017). Hemolysis can be detected by using
promoteinflammation(Longetal.,2016).Kallikreincandirectly
a photometric colorimetric test (cyanmethemoglobin method)
activateneutrophils(Wachtfogeletal.,1995)andbradykinincan
(Stadie, 1920). Thereby, the free amount of hemoglobin in stimulatethereleaseofnitricoxide(Baeetal.,2003),TNFα,and
plasma is examined after the addition of cyanmethemoglobin
IL-1 (Tiffany and Burch, 1989). Factor XIIa activates Factor XI
(CMH) reagent, e.g., Drabkin’s reagent, which rapidly converts
toXIaandinthefollowingstep,FactorIXisconvertedbyFactor
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 4 July2018|Volume6|Article99

--- Page 5 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
TABLE1|Summaryoftestcategoriesforthehemocompatibilityanalysisof recorded to obtain the activated PTT (aPTT). A shortened
biomaterials. clottingtimeindicatesanactivationoftheintrinsicandcommon
pathways of coagulation by the test material. Untreated plasma
Test Parameter Testprinciple
category isusedasnegativecontrolandlatexorblackrubberaspositive
control.
Complement C3a,C5a,Bb,C4d, ELISA
System C5b-9
ACTIVATION OF COMPLEMENT SYSTEM
Coagulation FactorXIIa,TAT,F1+ ELISA,Opticaldensity,
2,freeactivethrombin, Viscoelasticity
Complement system consists of more than 30 proteins
FPA,aPTT
circulating in the blood and present as membrane-associated
Fibrinolysis D-Dimers Immunoturbidimetry,
LPIA,ELISA proteins (Dunkelberger and Song, 2010). In response to the
Platelets β-TG,PF4,numberof ELISA,CellCounter, recognition of foreign surface structures, complement factors
platelets, are sequentially activated in an enzyme cascade via three
P-selectin,activated FACS different pathways: classical, alternative, and mannose binding
GPIIb/IIIa
lectin (MBL) pathway. All of these pathways lead to the
Hemolysis Numberof CellCounter generation of a C3 convertase, which cleaves C3 into a large
erythrocytes,
fragment C3b, which acts as an opsonin and a small fragment
Hemoglobin ColorimetricAssay
C3a, which is an anapylatoxin that promotes inflammation.
Leukocyte PMNelastase,ROS ELISA,fluorimetricor
Activation detection,CD11b spectrophotometric Afterwards, C5 convertase is generated, which cleaves C5 in
expression methods,FACS C5a, which is an anapylatoxin, and C5b that binds to the
Surface Plateletadhesion, SEM,Fluorescence foreign surface and initiates the generation of terminal lysis
Analysis aggregation,leukocyte microscopy complex (C5b-9, TCC), which is also called membrane attack
adhesion complex (MAC). As a result, microorganisms are eliminated
Plasmaprotein ELISA,WesternBlot
by lysis, opsonization and triggering a series of inflammatory
adsorption
reactions.
aPTT,activatedpartialthromboplastintime;β-TG,β-Thromboglobulin;C3a,Complement The contact of the artificial surface with blood leads to
factor3a;C5a,Complementfactor5a;C4d,Complementfactor4d;Bb,complement
an immediate adsorption of serum proteins, e.g., fibrinogen,
factorBb;ELISA,Enzyme-linkedImmunosorbentAssay;FACS,Fluorescence-activated
cell sorting; FPA, fibrinopeptide A; F1+2, Prothrombin fragment 1+2; LPIA, Latex albumin, and immunoglobulin G (IgG), to the surface of the
photometricimmunoassay;PF4,Plateletfactor4;TAT,thrombin-antithrombinIIIcomplex; material (Wetterö et al., 2000) and it results in a kinetic
PMN elastase, Polymorphonuclear elastase; ROS, Reactive oxygen species; SEM, competitionbetweentheproteinsonthematerialsurface,which
Scanningelectronmicroscopy.
is called the Vroman effect (Vroman et al., 1980). During the
first minutes, abundant proteins, such as fibrinogen, adsorb
XIatoIXa,whichthenactivatesfactorX.Theconversionoffactor and they are progressively displaced by less abundant proteins
X into factor Xa is the first common step in the coagulation with a higher affinity for the surface, such as HMWK, Factor
cascade between the intrinsic and extrinsic pathways (Millar XII, and plasminogen (Ballet et al., 2010). Especially, the
et al., 2016). In addition, the activation of complement system complementproteinC3andIgGcanreadilybindtohydrophobic
canleadtothegenerationofTFbymonocytes,whichcanresult surfaces and lead to the activation of complement system.
in activation of extrinsic pathway (Kappelmayer et al., 1993). Thereby, the following conformational changes on the blood-
FactorXaconvertsprothrombintothrombin,whichhydrolyses contacting surface are considered as initial trigger for the
fibrinogenintofibrinandleadstothesubsequentclotformation. complement activation via the alternative or classical pathway
Theactivationofcoagulationsystemisscreenedbydetection (GorbetandSefton,2004;Anderssonetal.,2005;Nilssonetal.,
of FXIIa (Basu et al., 2017), prothrombin fragment 1 + 2 (F1 2007).Differentbiomaterialsurfacesshowdifferentcomplement
+2)(Maitzetal.,2017;Sperlingetal.,2017),whichisreleased activatingproperties,forexample,hydrophobicsurfacescanlead
during thrombin formation, free active thrombin (Müller toanincreasedcomplementactivationcomparedtohydrophilic
et al., 2011), fibrinopeptide A (FPA) (Peckham et al., 1997), surfaces(Nilssonetal.,2007).
partial thromboplastin time (PTT), or thrombin-antithrombin The generated complement activation products lead to the
III complex (TAT). Furthermore, the degradation product of increased expression of P-selectin, which is an important
fibrin, D-dimer, can be detected by ELISA to determine the mediator of neutrophil recruitment and platelet accumulation
activation of fibrinolysis (Sperling et al., 2017). Antithrombin (Sukavaneshvar,2017).ComparedtoC3aandC4a,theproduced
III inhibits thrombin by forming a TAT complex. Thus, this C5a is the most powerful anaphylatoxin. It can increase the
complex reflects a functional state of the coagulation system permeability of blood vessels, attract and activate neutrophil
and can be quantified using ELISA. PTT assay measures the granulocytes and monocytes to stimulate phagocytosis. C5a
clottingtimefromtheactivationofFactorXIItotheformation stimulates endothelial cells to increasingly express cytokines,
of a stable fibrin clot. To detect PTT, citrated platelet-poor chemokines and cell adhesion molecules, such as E-selectin
plasma is incubated at 37◦C with the test material for 15, 30, (Newton and Dixit, 2012). Furthermore, it can bind to mast
or 60min. The addition of PTT reagent (cephalin) followed cellsandincreaseinflammation.Moreover,C5aisabletotrigger
by the addition of calcium chloride solution inactivates the the release of TF from neutrophils and monocytes, which can
anticoagulant and initiates clot formation and this time is initiatecoagulationcascade(Ikedaetal.,1997;Ritisetal.,2006;
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 5 July2018|Volume6|Article99

--- Page 6 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
Kourtzelisetal.,2010).Thus,thereisaclosecross-talkbetween further platelets passing by and lead to the adhesion and
the complement system and the coagulation pathway mediated aggregation of neighbored platelets. Finally, the thrombi is
bythegeneratedC5a(Oikonomopoulouetal.,2010). stabilizedbyfibrin.Alphagranulescontainhemostaticproteins,
Therefore, the analysis of complement activation is a highly suchasvWF,fibrinogen,FactorV,FactorIX,andplasminogen,
relevant criterion in the legislation for testing biomaterials chemokines (e.g., platelet factor 4 (PF4), SDF-1α), and growth
intended for blood contact. According to ISO 10993-4 factors (e.g., VEGF, PDGF). Furthermore, large amounts of β-
(International Organization for Standardization, 2000), the thromboglobulin (β-TG) are released from alpha granules after
complementactivationcanbeanalyzedbydetectionofC3a,C5a, the activation of platelets, which lead to leukocyte recruitment
Bb,iC3b,C4d,C3-,orC5-convertase,andtheC5b-9complexin (Brandtetal.,2000;Frohlich,2016).Inaddition,alphagranules
wholeblood,aswellasthe50%complementhemolyticactivity also contain integral membrane protein P-selectin, which is
(CH50) (Costabile, 2010). Most frequently, the concentration translocated to the plasma membrane after the activation of
ofanaphylatoxinsC3aandC5aaswellastheC5b-9complexis platelets (Frenette et al., 2000). P-selectin glycoprotein ligand-1
determinedusingELISA(Koppetal.,2002;Sperlingetal.,2007; (PSGL-1) expressed on leukocytes can interact with P-selectin
Engbergetal.,2011).Furthermore,inarecentstudy,Endgberg and lead to the activation of neutrophils (Sreeramkumar et al.,
andcolleaguesproposedthattheratiobetweenthebindingofC4 2014). Furthermore, the released polyphosphates can activate
and its inhibitor C4BP should be considered as a predictor for FactorXIIandleadtotheinitiationoftheintrinsiccoagulation
theevaluationofthehemocompatibility(Engbergetal.,2015). pathway(Mülleretal.,2009).
The activation of platelets can be determined according to
ISO10993-4bymeasuringreleasedcontentsfromalphagranules,
PLATELET ACTIVATION such as β-TG or PF4 using ELISA (Mayer et al., 2009; Teligui
etal.,2016;Stolletal.,2017)anddetectionofP-selectin(CD62P)
Platelets are present in large quantities in the blood and under oractivatedGPIIb/IIIareceptorwithPAC-1antibodyusingflow
physiological conditions, they circulate in a quiescent state for cytometry(Theoretetal.,2011;vanVelzenetal.,2012).
7–10days.Theadhesionandactivationofplateletsisprevented
by an healthy endothelial monolayer, which acts as a barrier
betweenbloodandtissuesandhasantithrombogenicproperties ACTIVATION OF LEUKOCYTES
by the release of e.g., nitric oxide (NO) and prostaglandin I
2
(PGI )(Brassetal.,2013;GolebiewskaandPoole,2015;Frohlich, Besides coagulation, complement, and platelet activation, the
2
2016).Thedamageofendotheliumleadstotheexposureofthe activationofleukocytesandtheoccurrenceofrespiratoryburst
underlying subendothelial collagen to the blood. In addition, can be analyzed to evaluate biomaterial-induced inflammatory
damagedendothelialcellssecretevonWillebrandfactor(vWF), response.Thus,thegenerationofreactiveoxygenspecies(ROS)
which can bind to the collagen in the exposed subendothelial and the release of PMN elastase are the mainly determined
layerandmediatetheadhesionofcirculatingplatelets(Yauetal., parametersforleukocytesactivation.Theactivationofleukocytes
2015)toformasealatthedamagedarea. leadstoarespiratoryburst(DahlgrenandKarlsson,1999),which
The exposure of biomaterial to the blood can result in is the result of an enhanced oxygen metabolism, and results in
−
an undesired activation of platelets and consequently lead generationofROS(superoxide anion(O ),hydrogenperoxide
2
to thrombotic complications. Thus, the analysis of platelet (H O ),hydroxylradical(HO • )andsingletoxygen(1O ).Thus,
2 2 2
activation is an important part of hemocompatibility tests. the ROS generation can be detected (Roesslein et al., 2013)
The contact of blood with foreign surfaces immediately leads using chemiluminogenic (Nygren et al., 2000) or fluorogenic
to the adsorption of plasma proteins, especially fibrinogen, substances (Ferrer et al., 2013). Furthermore, the release of
immunoglobulins, fibronectin, vitronectin, Factor XI and XII, elastasefromPMNgranulocytes,especiallyfromneutrophils,can
vWF, HMWK, and PK to the biomaterial surface (Long bequantifiedbyELISA(Zimmermannetal.,2007).Additionally,
et al., 2016). Particularly, fibrinogen, vWF, fibronectin, and PMN elastase activity can also be measured by the proteolytic
vitronectin induce the adhesion of platelets via interaction cleavageofasyntheticsubstrateandthereleaseofafluorophore,
with the most frequent integrin receptor α β glycoprotein whichcanbeeasilyquantifiedbyfluorescence(Gramegnaetal.,
IIb 3
IIb/IIIa (GPIIb/IIIa) on the surface of platelets and lead to the 2017).
activation of platelets. Subsequently, platelets release bioactive Theactivationofleukocytesleadstotheincreasedexpression
molecules from their alpha and dense granules. Each platelet of CD11b on the cell surface via translocation of the CD11b
contains ∼50–80 alpha granules and ∼3–6 dense granules from intracellular granules to the plasma membrane. Thus, the
(Fitch-Tewfik and Flaumenhaft, 2013). The dense granules detectionofCD11bexpressiononthesurfaceofleukocytesusing
contain proaggregatory factors such as adenosine diphosphate fluorescence-activated cell sorting (FACS) can give additional
(ADP), adenosine triphosphate (ATP), histamine, serotonin information on activation of leukocytes (Gorbet et al., 1999).
[5-hydroxytryptamine (5-HT)], polyphosphates, and bivalent Furthermore, the production of neutrophil extracellular traps
cations
Mg2+
and
Ca2+
(Meyers et al., 1982). ADP can (NETs) is a recently described mechanism of neutrophils for
activate neighboring platelets via binding to two different host defense (Brinkmann et al., 2004; Delgado-Rizo et al.,
purinergic receptors on platelets, known as P2Y and P2Y 2017).DuringNETosis,thenuclearmaterialisreleasedinform
1 12
(WijeyeratneandHeptinstall,2011).Theseplateletscanactivate of a meshwork of chromatin by activated neutrophils to the
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 6 July2018|Volume6|Article99

--- Page 7 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
FIGURE3|Scanningelectronmicroscopic(SEM)analysisofsyntheticvasculargraftsurfaceafterthebloodcontact.Arrowsindicatetheadheredplateletsaswellas
theresulting3D-fibrinmeshesduetoactivationofbloodcoagulation.Theanalyseswereperformedinourworkinggroupandthedatahasnotbeenpublishedbefore.
extracellular space (Noubouossie et al., 2017). Several proteins release of vasoconstrictive substances, such as thromboxane
adhere to the NETs, such as histones and components with and PDGF, as well as contents of stored granules occur.
antimicrobialactivity,e.g.,elastaseandmyeloperoxide(Delgado- Finally, the aggregation of platelets and the generation of
Rizoetal.,2017).Besidestheabilitytotrapbacteria,NETsability a fibrin network can be analyzed using scanning electron
topromotethrombosiswasdemonstratedinanimalmodels(Brill microscopy (SEM) (Zhang et al., 2017) (Figure3). Thus, in
etal.,2012). several studies, the surface thrombogenicity of biomaterials
was examined by characterization of cell morphology and
ANALYSIS OF BIOMATERIAL SURFACES spreadingusingSEM(BalasubramanianandSlack,2001;Aguilar
etal.,2002).Furthermore,usingfluorescentlylabeledantibodies
The adsorption of proteins to the surface of biomaterials is the against specific receptors, the adhered cells and the cell density
initialstepdirectlyafterthebloodcontact.Subsequently,adhered can be detected using fluorescence and confocal microscopy
proteins initiate the adhesion and activation of platelets on the (Nguyenetal.,2016).Inrecentyears,microgravimetricanalyses
surface.Theseplateletscanfurtheractivateneighboredplatelets using quartz crystal microbalance (QCM) were also applied to
andatthelaststepthethrombiarestabilizedbythegenerationof investigatetheplateletadhesionandactivation(Sinnetal.,2010;
afibrinnetwork. Fatisson et al., 2011; Kunze et al., 2014). Moreover, Hanson
The activation of platelets is a very fast process of ∼180ms and colleagues used surface plasmon resonance (SPR) based
(van Oeveren, 2013) and different morphological appearance flow chamber device to detect platelet-surface interactions and
of platelets can be detected on material surfaces depending on blood coagulation (Hansson et al., 2007). Furthermore, Zhao
varying states of activation: (1) unactivated platelets: round, et al. (2011) used SEM and transmission electron microscopy
discoid shaped without pseudopodia, (2) partially activated (TEM)toinvestigatetheeffectofdifferentsizesofnanoparticles
platelets: dendritic with early pseudopodia, (3) moderately on hemolysis and the mechanism behind the lysis of red
activated platelets: spread-dendritic with irreversible long- bloodcells.Thegroupdemonstratedthatasmallproportionof
dendritic extensions, (4) fully activated platelets: fully spread smalltypeofmesoporoussilicananoparticles(MSNs)adsorbed
(Parketal.,1990). to the surface of erythrocytes without any alteration of cell
Theadhesionandactivationofplateletsleadtoacytoskeletal membrane or morphology. In contrast, the adsorption of large
rearrangement and therefore to a morphological change of typeMSNstotheerythrocytesinducedastronglocalmembrane
platelets on the biomaterial surface with extensive formation deformation and resulted in internalization of particles and
of pseudopodia. Afterwards, the spreading of platelets and the hemolysis.
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 7 July2018|Volume6|Article99

--- Page 8 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
CONCLUSION hemocompatibility. Furthermore, to prove the safety and
reliability of new products, hemocompatibility analyses should
The interaction of biomaterials with blood leads to cellular include appropriate references and follow the ISO 10993-4
as well as humoral reactions, which can result in an standard.
unwanted inflammation and activation of coagulation and/or
fibrinolysis. Thus, the development of biomaterials with an AUTHOR CONTRIBUTIONS
improved hemocompatibility increases the tolerability and
minimizes unwanted side effects, such as thrombus formation. MA-A is the corresponding author of this work. She
Therefore, during the development of new blood-contacting developed the outline with HW and CS edited the paper.
medical devices, not only the mechanical and chemical MWandMA-Awrotethemanuscript.HS,SG,andLHrevised
characteristics should play an important role, but also the themanuscript.
REFERENCES
Cerda-Cristerna, B. I., Flores, H., Pozos-Guillén, A., Pérez, E., Sevrin, C., and
Grandfils,C.(2011).Hemocompatibilityassessmentofpoly(2-dimethylamino
Aguilar,M.R.,Rodríguez,G.,Fernández,M.,Gallardo,A.,andSanRomán,J. ethylmethacrylate)(PDMAEMA)-based polymers. J. Control. Release 153,
(2002).Polymericactivecoatingswithfunctionalityinvascularapplications. 269–277.doi:10.1016/j.jconrel.2011.04.016
J. Mater. Sci. Mater. Med. 13, 1099–1104. doi: 10.1023/A:10211009 Costabile,M.(2010).Measuringthe50%haemolyticcomplement(CH50)activity
16920 ofserum.J.Vis.Exp.37:1923.doi:10.3791/1923
Andersson, J., Ekdahl, K. N., Lambris, J. D., and Nilsson, B. (2005). Binding Dahlgren,C.,andKarlsson,A.(1999).Respiratoryburstinhumanneutrophils.J.
of C3 fragments on top of adsorbed plasma proteins during complement Immunol.Methods.232,3–14.
activation on a model biomaterial surface. Biomaterials 26, 1477–1485. Delgado-Rizo, V., Martínez-Guzmán, M. A., Iñiguez-Gutierrez, L., García-
doi:10.1016/j.biomaterials.2004.05.011 Orozco,A.,Alvarado-Navarro,A.,andFafutis-Morris,M.(2017).Neutrophil
Bae,S.W.,Kim,H.S.,Cha,Y.N.,Park,Y.S.,Jo,S.A.,andJo,I.(2003).Rapid extracellulartrapsanditsimplicationsininflammation:anoverview.Front.
increaseinendothelialnitricoxideproductionbybradykininismediatedby Immunol.8:81.doi:10.3389/fimmu.2017.00081
protein kinase A signaling pathway. Biochem. Biophys. Res. Commun. 306, Dunkelberger,J.R.,andSong,W.-C.(2010).Complementanditsroleininnate
981–987.doi:10.1016/S0006-291X(03)01086-6 andadaptiveimmuneresponses.CellRes.20,34–50.doi:10.1038/cr.2009.139.
Balasubramanian, V., and Slack, S. M. (2001). Effects of fibrinogen residence Engberg,A.E.,Nilsson,P.H.,Huang,S.,Fromell,K.,Hamad,O.A.,Mollnes,T.E.,
time and shear rate on the morphology and procoagulant activity of etal.(2015).Predictionofinflammatoryresponsesinducedbybiomaterialsin
humanplateletsadherenttopolymericbiomaterials.ASAIOJ.47,354–360. contactwithhumanbloodusingproteinfingerprintfromplasma.Biomaterials
doi:10.1097/00002480-200107000-00012 36,55–65.doi:10.1016/j.biomaterials.2014.09.011
Ballet,T.,Boulange,L.,Brechet,Y.,Bruckert,F.,andWeidenhaupt,M.(2010). Engberg,A.E.,Rosengren-Holmberg,J.P.,Chen,H.,Nilsson,B.,Lambris,J.D.,
Proteinconformationalchangesinducedbyadsorptionontomaterialsurfaces: Nicholls,I.A.,etal.(2011).Bloodprotein-polymeradsorption:implicationsfor
animportantissueforbiomedicalapplicationsofmaterialscience.Bull.Pol. understandingcomplement-mediatedhemoincompatibility.J.Biomed.Mater.
Acad.Sci.Tech.Sci.58,303–313.doi:10.2478/v10175-010-0028-0 Res.A97,74–84.doi:10.1002/jbm.a.33030
Basu, A., Hong, J., and Ferraz, N. (2017). Hemocompatibility of Ca(2+) Fatisson, J., Mansouri, S., Yacoub, D., Merhi, Y., and Tabrizian, M. (2011).
-crosslinked nanocellulose hydrogels: toward efficient management of Determination of surface-induced platelet activation by applying
hemostasis.Macromol.Biosci.17.doi:10.1002/mabi.201700236 time-dependency dissipation factor versus frequency using quartz
Biró,E.K.,Sturk-Maquelin,Vogel,G.,Meuleman,D.,Smit,M.,Hack,C.,etal. crystal microbalance with dissipation. J. R. Soc. Interface 8, 988–997.
(2003).Humancell-derivedmicroparticles promotethrombusformationin doi:10.1098/rsif.2010.0617
vivoinatissuefactor-dependentmanner.J.Thromb.Haemost.1,2561–2568. Ferrer,M.C.,Eckmann,U.N.,Composto,R.J.,andEckmann,D.M.(2013).
doi:10.1046/j.1538-7836.2003.00456.x Hemocompatibility and biocompatibility ofantibacterial biomimetic hybrid
Blok, L. J. S., Engels, G. E., and van Oeveren, W. (2016). In vitro films.Toxicol.Appl.Pharmacol.272,703–712.doi:10.1016/j.taap.2013.07.023
hemocompatibility testing: the importance of fresh blood. Biointerphases Fitch-Tewfik, J. L., and Flaumenhaft, R. (2013). Platelet granule exocytosis:
11:029802.doi:10.1116/1.4941850 a comparison with chromaffin cells. Front. Endocrinol. (Lausanne) 4:77.
Brandt,E.,Petersen,F.,Ludwig,A.,Ehlert,J.E.,Bock,L.,andFlad,H.D.(2000). doi:10.3389/fendo.2013.00077
Thebeta-thromboglobulinsandplateletfactor4:bloodplatelet-derivedCXC Frenette,P.S.,Denis,C.V.,Weiss,L.,Jurk,K.,Subbarao,S.,Kehrel,B.,etal.
chemokineswithdivergentrolesinearlyneutrophilregulation.J.Leukoc.Biol. (2000).P-Selectinglycoproteinligand1(PSGL-1)isexpressedonplateletsand
67,471–478.doi:10.1002/jlb.67.4.471 canmediateplatelet-endothelialinteractionsinvivo.J.Exp.Med.191,1413–22.
Brass, L. F., Tomaiuolo, M., and Stalker, T. J. (2013). Harnessing the platelet doi:10.1084/jem.191.8.1413
signalingnetworktoproduceanoptimalhemostaticresponse.Hematol.Oncol. Frohlich, E. (2016). Action of nanoparticles on platelet activation
Clin.NorthAm.27,381–409.doi:10.1016/j.hoc.2013.02.002 and plasmatic coagulation, Curr. Med. Chem. 23, 408–430.
Braune, S., Grunze, M., Straub, A., and Jung, F. (2013). Are there sufficient doi:10.2174/0929867323666160106151428
standards for the in vitro hemocompatibility testing of biomaterials?. Golebiewska, E. M., and Poole, A. W. (2015). Platelet secretion: from
Biointerphases8:33.doi:10.1186/1559-4106-8-33 haemostasis to wound healing and beyond. Blood Rev. 29, 153–162.
Brill,A.,Fuchs,T.,Savchenko,A.,Thomas,G.,Martinod,K.,DeMeyer,S.,etal. doi:10.1016/j.blre.2014.10.003
(2012).Neutrophilextracellulartrapspromotedeepveinthrombosisinmice.J. Gorbet,M.B.,andSefton,M.V(2004).Biomaterial-associatedthrombosis:roles
Thromb.Haemost.10,136–144.doi:10.1111/j.1538-7836.2011.04544.x ofcoagulationfactors,complement,plateletsandleukocytes.Biomaterials25,
Brinkmann,V.,Reichard,U.,Goosmann,C.,Fauler,B.,Uhlemann,Y.,Weiss,D.S., 5681–703.doi:10.1016/j.biomaterials.2004.01.023
etal.(2004)Neutrophilextracellulartrapskillbacteria.Science303,1532–1535. Gorbet, M., Yeo, E., and Sefton, M. (1999). Flow cytometric study of in vitro
doi:10.1126/science.1092385 neutrophilactivationbybiomaterials.J.Biomed.Mater.Res.A44,289–297.
Camci-Unal, G., Cuttica, D., Annabi, N., Demarchi, D., and Khademhosseini, Gramegna, A., Amati, F., Terranova, L., Sotgiu, G., Tarsia, P., Miglietta, D.,
A. (2013). Synthesis and characterization of hybrid hyaluronic acid-gelatin et al. (2017). Neutrophil elastase in bronchiectasis. Respir. Res. 18:211.
hydrogels.Biomacromolecules14,1085–1092.doi:10.1021/bm3019856 doi:10.1186/s12931-017-0691-x
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 8 July2018|Volume6|Article99

--- Page 9 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
Hansson,K.M.,Johansen,K.,Wetterö,J.,Klenkar,G.,Benesch,J.,Lundström, Mayer,A.,Vadon,M.,Rinner,B.,Novak,A.,Wintersteiger,R.,andFrohlich,E.
I., et al. (2007). Surface plasmon resonance detection of blood coagulation (2009).Theroleofnanoparticlesizeinhemocompatibility. Toxicology 258,
and platelet adhesion under venous and arterial shear conditions. Biosens. 139–147.doi:10.1016/j.tox.2009.01.015
Bioelectron.23,261–268.doi:10.1016/j.bios.2007.04.009 McClung, W. G., Babcock, D., and Brash, J. (2007). Fibrinolytic properties of
Haycox, C.L.,and Ratner,B.D(1993).In vitroplatelet interactions inwhole lysine-derivatizedpolyethyleneincontactwithflowingwholeblood(Chandler
humanbloodexposedtobiomaterialsurfaces:insightsonbloodcompatibility. loop model). J. Biomed. Mater. Res. A 81, 644–651. doi: 10.1002/jbm.a.
J.Biomed.Mater.Res.A27,1181–1193. 31018
International Organization for Standardization (2000). Biological Evaluation of Meyers,K.M.,Holmsen,H.,andSeachord,C.L.(1982).Comparativestudyof
MedicalDevices.Availableonlineathttps://www.iso.org/standard/63448.html plateletdensegranuleconstituents.Am.J.Physiol.243,R454–R461.
(AccessedApril23,2018). Millar, J. E., Fanning, J. P., McDonald, C. I., McAuley, D. F., and Fraser,
Ikeda,K.,Nagasawa,K.,Horiuchi,T.,Tsuru,T.,Nishizaka,H.,andNiho,Y.(1997). J. F. (2016). The inflammatory response to extracorporeal membrane
C5ainducestissuefactoractivityonendothelialcells.Thromb.Haemost.77, oxygenation (ECMO): a review of the pathophysiology. Crit. Care 20:387.
394–398. doi:10.1186/s13054-016-1570-4
Kälsch, T., Elmas, E., Nguyen, X. D., Suvajac, N., Klüter, H., Borggrefe, Mohan,C.C.,Chennazhi,K.P.,andMenon,D.(2013).Invitrohemocompatibility
M. et al. (2007). Endotoxin-induced effects on platelets and monocytes and vascular endothelial cell functionality on titania nanostructures under
in an in vivo model of inflammation. Basic Res. Cardiol. 102, 460–466. staticanddynamicconditionsforimprovedcoronarystentingapplications.
doi:10.1007/s00395-007-0667-y ActaBiomater.9,9568–9577.doi:10.1016/j.actbio.2013.08.023
Kappelmayer,J.,Bernabei,A.,Edmunds,L.H.,Edgington,T.S.,andColman, Müller, F., Mutch, N. J., Schenk, W. A., Smith, S. A., Esterl, L., Spronk,
R. W. (1993). Tissue factor is expressed on monocytes during simulated H. M., et al. (2009). Platelet polyphosphates are proinflammatory and
extracorporealcirculation.Circ.Res.72,1075–1081. procoagulantmediatorsinvivo.Cell139,1143–1156.doi:10.1016/j.cell.2009.
Kent, N. J., Basabe-Desmonts, L., Meade, G., MacCraith, B. D., Corcoran, B. 11.001
G., Kenny, D., et al. (2010). Microfluidic device to study arterial shear- Müller, J., Becher, T., Braunstein, J., Berdel, P., Gravius, S., Rohrbach,
mediatedplatelet-surfaceinteractionsinwholeblood:reducedsamplevolumes F., et al. (2011). Profiling of active thrombin in human blood by
andwell-characterisedproteinsurfaces.Biomed.Microdevices12,987–1000. supramolecular complexes. Angew. Chem. Int. Ed. Engl. 50, 6075–6078.
doi:10.1007/s10544-010-9453-y. doi:10.1002/anie.201007032
Kopp,R.,Mottaghy,K.,andKirschfink,M.(2002).Mechanismofcomplement Müller, M., Krolitzki, B., and Glasmacher, B. (2012). Dynamic in vitro
activation during extracorporeal blood-biomaterial interaction: effects hemocompatibilitytesting–improvingthesignaltonoiseratio.Biomed.Eng.
of heparin coated and uncoated surfaces. ASAIO J. 48, 598–605. 57,549–552.doi:10.1515/bmt-2012-4211
doi:10.1097/00002480-200211000-00005 Nagy, M., Heemskerk, J. W., and Swieringa, F. (2017). Use of microfluidics
Kourtzelis, I., Markiewski, M. M., Doumas, M., Rafail, S., Kambas, to assess the platelet-based control of coagulation. Platelets 28, 441–448.
K., Mitroulis, I., et al. (2010). Complement anaphylatoxin C5a doi:10.1080/09537104.2017.1293809
contributes to hemodialysis-associated thrombosis. Blood 116, 631–639. Neun, B. W., and Dobrovolskaia, M. A. (2011). “Method for analysis
doi:10.1182/blood-2010-01-264051 of nanoparticle hemolytic properties in vitro,” in Characterization of
Kovach, K. M., Capadona, J. R., Gupta, A. S., and Potkay, J. A. (2014). Nanoparticles Intended for Drug Delivery (Humana Press), 215–224.
The effects of PEG-based surface modification of PDMS microchannels on doi:10.1007/978-1-60327-198-1
long-term hemocompatibility. J. Biomed. Mater. Res. A 102, 4195–4205. Newton, K., and Dixit, V. M. (2012). Signaling in innate immunity
doi:10.1002/jbm.a.35090 and inflammation. Cold Spring Harb. Perspect. Biol. 4:a006049.
Krajewski, S., Prucek, R., Panacek, A., Avci-Adali, M., Nolte, A., Straub, A., doi:10.1101/cshperspect.a006049.
et al. (2013). Hemocompatibility evaluation of different silver nanoparticle Nilsson,B.,Ekdahl,K.N.,Mollnes,T.E.,andLambris,J.D.(2007).Theroleof
concentrationsemployingamodifiedChandler-loopinvitroassayonhuman complementinbiomaterial-inducedinflammation.Mol.Immunol.44,82–94.
blood.ActaBiomater.9,7460–7468.doi:10.1016/j.actbio.2013.03.016 doi:10.1016/j.molimm.2006.06.020
Kuhbier, J., Coger, V., Mueller, J., Liebsch, C., Schlottmann, F., Bucan, V., Nguyen, T.-H., Palankar, V.-R., Bui, C., Medvedev, N., Greinacher, A.,
et al. (2017). Influence of direct or indirect contact for the cytotoxicity and Delcea, M. (2016). Rupture forces among human blood platelets
and blood compatibility of spider silk. J. Mater. Sci. Mater. Med. 28:127. at different degrees of activation. Sci. Rep. 6:25402. doi: 10.1038/srep
doi:10.1007/s10856-017-5936-1 25402
Kunze,A.,Hesse,C.,andSvedhem,S.(2014).Real-timemonitoringofsurface- Nordling,S.,Nilsson,B.,andMagnusson,P.U(2014).Anovelinvitromodelfor
confinedplateletactivationonTio2.ColloidsSurf.BBiointerfaces116,446–451. studyingtheinteractionsbetweenhumanwholebloodandendothelium.J.Vis.
doi:10.1016/j.colsurfb.2014.01.025 Exp.96:e52112.doi:10.3791/52112
Lackner, J. M., Waldhauser, W., Hartmann, P., Bruckert, F., Weidenhaupt, Noubouossie, D. F., Whelihan, M. F.,Yu, Y.-B., Sparkenbaugh, E.,
M.,Major,R.,etal.(2012).Hemocompatibilityofinorganicphysicalvapor Pawlinski, R., and Key, N. (2017). In vitro activation of coagulation
deposition(PVD)coatingsonthermoplasticpolyurethanepolymers.J.Funct. by human neutrophil DNA and histone proteins but not neutrophil
Biomater.3,283–297.doi:10.3390/jfb3020283. extracellular traps. Blood 129, 1021–1029. doi: 10.1182/blood-2016-06-7
Li, Y., and Boraschi, D. (2016). Endotoxin contamination: a key element 22298
in the interpretation of nanosafety studies. Nanomedicine 11, 269–287. Nygren, H., Braide, M., and Karlsson, C. (2000). Different kinetics of the
doi:10.2217/nnm.15.196 respiratory burst response in granulocytes, induced by serum from blood
Liu, X., Yuan, L., Li, D., Tang, Z., Wang, Y., Chen, G., et al. (2014). Blood coagulated in contact with polymer materials. Biomaterials 21, 173–182.
compatible materials: state of the art. J. Mater. Chem. B 2, 5718–5738. doi:10.1016/S0142-9612(99)00146-5
doi:10.1039/C4TB00881B Oikonomopoulou, K., Ricklin, D., Ward, P. A., and Lambris, J.
Long, A. T., Kenne, E., Jung, R., Fuchs, T. A., and Renné, T. (2016). Contact D. (2010). Interactions between coagulation and complement—
systemrevisited:aninterfacebetweeninflammation,coagulation,andinnate their role in inflammation. Semin. immunopathol. 34, 151–165.
immunity.J.Thromb.Haemost.14,427–437.doi:10.1111/jth.13235 doi:10.1007/s00281-011-0280-x.
Magalhães, P. O., Lopes, A. M., Mazzola, P. G., Rangel-Yagui, C., Penna, T., Onasoga-Jarvis, A., Puls, T., O’brien, S., Kuang, L., Liang, H., and Neeves,
and Pessoa, A. Jr. (2007). Methods of endotoxin removal from biological K. (2014). Thrombin generation and fibrin formation under flow on
preparations:areview.J.Pharm.Pharm.Sci.10,388–404. biomimetic tissue factor-rich surfaces. J. Thromb. Haemost. 12, 373–382.
Maitz, M. F., Sperling, C., Wongpinyochit, T., Herklotz, M., Werner, C., doi:10.1111/jth.12491
and Seib, F. P. (2017). Biocompatibility assessment of silk nanoparticles: Onasoga-Jarvis,A.A.,Leiderman,K.,Fogelson,A.L.,Wang,M.,Manco-Johnson,
hemocompatibilityandinternalizationbyhumanbloodcells.Nanomedicine13, M.J.,DiPaola,J.A.,etal.(2013).TheeffectoffactorVIIIdeficienciesand
2633–2642.doi:10.1016/j.nano.2017.07.012 replacementandbypasstherapiesonthrombusformationundervenousflow
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 9 July2018|Volume6|Article99

--- Page 10 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
conditions inmicrofluidic and computational models. PLoS ONE 8:e78732. Teligui, L., Dalmayrac, E., Corbeau, J. J., Bouquet, E., Godon, A., Denomme,
doi:10.1371/journal.pone.0078732 A. S., et al. (2016). Ex vivo simulation of cardiopulmonary bypass
Park,K.,Mao,F.,andPark,H.(1990).Morphologicalcharacterizationofsurface- with human blood for hemocompatibility testing. Perfusion 31, 376–83.
inducedplateletactivation.Biomaterials11,24–31. doi:10.1177/0267659115599454
Peckham, S. M., Turitto, V. T., Glantz, J., Puryear, H., and Slack, S. (1997). Théorêt, J. F., Yacoub, D., Hachem, A., Gillis, M. A., and Merhi, Y.
Hemocompatibility studies of surface-treated polyurethane-based chronic (2011). P-selectin ligation induces platelet activation and enhances
indwellingcatheters.J.Biomater.Sci.8,847–858. microaggregate and thrombus formation. Thromb. Res. 128, 243–50.
Podias, A., Groth, T., and Missirlis, Y. (1995). The effect of shear rate on the doi:10.1016/j.thromres.2011.04.018.
adhesion/activationofhumanplateletsinflowthroughaclosed-looppolymeric Thorsen, T., Klausen, H., Lie, R., and Holmsen, H. (1993) Bubble-induced
tubularsystem.J.Biomater.Sci.6,399–410. aggregationofplatelets:effectsofgasspecies,proteins,anddecompression.
Punet,X.,Mauchauffé,R.,Rodríguez-Cabello,J.C.,Alonso,M.,Engel,E.,and UnderseaHyperb.Med.20,101–119.
Mateos-Timoneda,M.A.(2015).Biomolecularfunctionalizationforenhanced Tiffany,C.W.,andBurch,R.M.(1989).Bradykininstimulatestumornecrosis
cell–material interactions of poly (methyl methacrylate) surfaces. Regen. factorandinterleukin-1releasefrommacrophages.FEBSLett.247,189–192.
Biomater.2,167–175.doi:10.1093/rb/rbv014 Totea, G., Ionita, D., Demetrescu, I., and Mitache, M. (2014). In vitro
Qian, Q., Nath, K. A., Wu, Y., Daoud, T. M., and Sethi, S. (2010). hemocompatibilityandcorrosionbehaviorofnewZr-binaryalloysinwhole
Hemolysis and acute kidney failure. Am. J. Kidney Dis. 56, 780–784. humanblood.OpenChem.12,796–803.doi:10.2478/s11532-014-0535-1
doi:10.1053/j.ajkd.2010.03.025 VafaHomann,M.,Johansson,D.,Wallen,H.,andSanchez,J.(2016).Improved
Ritis,K.,Doumas,M.,Mastellos,D.,Micheli,A.,Giaglis,S.,Magotti,P.,etal. ex vivo blood compatibility of central venous catheter with noble metal
(2006). A novel C5a receptor-tissue factor cross-talk in neutrophils links alloy coating. J. Biomed. Mater. Res. B Appl. Biomater. 104, 1359–1365.
innate immunity to coagulation pathways. J. Immunol. 177, 4794–4802. doi:10.1002/jbm.b.33403
doi:10.4049/jimmunol.177.7.4794 VanKruchten,R.,Cosemans,J.M.,andHeemskerk,J.W.(2012).Measurement
Ritz-Timme,S.,Eckelt,N.,Schmidtke,E.,andThomsen,H.(1997).Genesisand of whole blood thrombus formation using parallel-plate flow chambers–
diagnosticvalueofleukocyteandplateletaccumulationsaround“airbubbles” a practical guide. Platelets 23, 229–242. doi: 10.3109/09537104.2011.6
inbloodaftervenousairembolism.Int.J.Leg.Med.111,22–26. 30848
Roesslein, M., Hirsch, C., Kaiser, J.-P., Krug, H. F., and Wick, P. (2013). van Oeveren, W. (2013). Obstacles in haemocompatibility testing. Scientifica
Comparabilityofinvitrotestsforbioactivenanoparticles:acommonassayto 2013:392584.doi:10.1155/2013/392584
detectreactiveoxygenspeciesasanexample.Int.J.Mol.Sci.14,24320–24337. VanOeveren,W.,Tielliu,I.F.,andDeHart,J.(2012).Comparisonofmodified
doi:10.3390/ijms141224320 chandler,rollerpump,andballvalvecirculationmodelsforinvitrotesting
Sanak,M,Jakieła,B.,andWegrzyn,W.(2010).Assessmentofhemocompatibility in high blood flow conditions: application in thrombogenicity testing of
ofmaterialswitharterialbloodflowbyplateletfunctionaltests.Bull.Polish different materials for vascular applications. Int. J. Biomater. 2012:673163.
Acad.Sci.Tech.Sci.58,317–322.doi:10.2478/v10175-010-0029-z doi:10.1155/2012/673163
Schrottmaier, W. C., Kral, J. B., Zeitlinger, M., Salzmann, M., Jilma, B., and van Velzen, J. F., Laros-van Gorkom, Pop, G. A., and van Heerde,
Assinger,A.(2016).Plateletactivationattheonsetofhumanendotoxemiais W. L. (2012). Multicolor flow cytometry for evaluation of platelet
undetectableinvivo.Platelets27,479–483.doi:10.3109/09537104.2015 surface antigens and activation markers. Thromb. Res. 130,92–98.
Sinn, S., Müller, L., Drechsel, H., Wandel, M., Northoff, H., Ziemer, G., et al. doi:10.1016/j.thromres.2012.02.041
(2010).Plateletaggregationmonitoringwithanewlydevelopedquartzcrystal Vroman,L.,Adams,A.L,Fischer,G.C.,andMunoz,P.C.(1980).Interaction
microbalancesystemasanalternativetoopticalplateletaggregometry.Analyst ofhighmolecularweightkininogen,factorXII,andfibrinogeninplasmaat
135,2930–2938.doi:10.1039/c0an00474j interfaces.Blood55,156–159.
Sinn,S.,Scheuermann,T.,Deichelbohrer,S.,Ziemer,G.,andWendel,H.P.(2011). Wachtfogel,Y.T.,Hack,C.E.,Nuijens,J.,Kettner,C.,Reilly,T.M.,Knabb,R.
A novel in vitro model for preclinical testing of the hemocompatibility of M.,etal.(1995).Selectivekallikreininhibitorsalterhumanneutrophilelastase
intravascularstentsaccordingtoISO10993-4.J.Mater.Sci.Mater.Med.22, releaseduringextracorporealcirculation.Am.J.Physiol.268,H1352–H1357.
1521–1528.doi:10.1007/s10856-011-4335-2 Wang,D.-A.,Ji,J.,Gao,C.-Y.,Yu,G.-H.,andFeng,L.-X.(2001)Surfacecoating
Sperling, C., Maitz, M. F., Grasso, S., Werner, C., and Kanse, S. M. (2017). of stearyl poly (ethylene oxide) coupling-polymer on polyurethane guiding
A positively charged surface triggers coagulation activation through factor catheters with poly (ether urethane) film-building additive for biomedical
VIIactivatingprotease(FSAP).ACSAppl.Mater.Interfaces9,40107–40116. applications. Biomaterials 22, 1549–1562. doi: 10.1016/S0142-9612(00)00
doi:10.1021/acsami.7b14281 311-2
Sperling,C.,Maitz,M.F.,Talkenberger,S.,Gouzy,M.F.,Groth,T.,andWerner,C. Watanabe, J., Marathe, G. K., Neilsen, P. O., Weyrich, A. S., Harrison, K. A.,
(2007).Invitrobloodreactivitytohydroxylatedandnon-hydroxylatedpolymer Murphy,R.C.,etal.(2003).Endotoxinsstimulateneutrophiladhesionfollowed
surfaces.Biomaterials28,3617–3625.doi:10.1016/j.biomaterials.2007.04.041 bysynthesisandreleaseofplatelet-activatingfactorinmicroparticles.J.Biol.
Sreeramkumar, V., Adrover, J. M., Ballesteros, I., Cuartero, M. I., Rossaint, J., Chem.278,33161–33168.doi:10.1074/jbc.M305321200
Bilbao, I., et al. (2014) Neutrophils scan for activated platelets to initiate Westein, E., de Witt, S., Lamers, M., Cosemans, J. M., and Heemskerk,
inflammation.Science346,1234–1238.doi:10.1126/science.1256478 J. W. (2012). Monitoring in vitro thrombus formation with novel
Stadie,W.C(1920).Amethodforthedeterminationofmethaemoglobininthe microfluidic devices. Platelets 23, 501–509. doi: 10.3109/09537104.2012.7
blood.J.Biol.Chem.41,237–241. 09653
Stang,K.,Krajewski,S.,Neumann,B.,Kurz,J.,Post,M.,Stoppelkamp,S.,etal. Wetterö, J., Bengtsson, T., and Tengvall, P. (2000). Complement activation
(2014).HemocompatibilitytestingaccordingtoISO10993-4:discrimination on immunoglobulin G-coated hydrophobic surfaces enhances the
betweenpyrogen-anddevice-inducedhemostaticactivation.Mater.Sci.Eng.C release of oxygen radicals from neutrophils through an actin-dependent
42,422–428.doi:10.1016/j.msec.2014.05.070 mechanism. J. Biomed. Mater. Res. 51, 742–751. doi: 10.1002/1097-
Stoll,H.,Steinle,H.,Stang,K.,Kunnakattu,S.,Scheideler,L.,Neumann,B.,etal. 4636(20000915)51:4<742::AID-JBM24>3.0.CO;2-D
(2017).GenerationofLarge-ScaleDNAHydrogelswithexcellentbloodandcell Wijeyeratne, Y. D., and Heptinstall, S. (2011). Anti-platelet therapy:
compatibility.Macromol.Biosci.17:1600252.doi:10.1002/mabi.201600252. ADP receptor antagonists. Br. J. Clin. Pharmacol. 72, 647–57.
Streller,U.,Sperling,C.,Hübner,J.,Hanke,R.,andWerner,C.(2003).Designand doi:10.1111/j.1365-2125.2011.03999.x
evaluationofnovelbloodincubationsystemsforinvitrohemocompatibility Wu, Y. (2015). Contact pathway of coagulation and inflammation. Thromb. J.
assessmentofplanarsolidsurfaces.J.Biomed.Mater.Res.BAppl.Biomater.66, 13:17.doi:10.1186/s12959-015-0048-y
379–390.doi:10.1002/jbm.b.10016 Xiao,W.,He,J.,Nichol,J.W.,Wang,L.,Hutson,C.B.,Wang,B.,etal.(2011).
Sukavaneshvar,S.(2017).Devicethrombosisandpre-clinicalbloodflowmodels Synthesisandcharacterizationofphotocrosslinkablegelatinandsilkfibroin
for assessing antithrombogenic efficacy of drug-device combinations. Adv. interpenetrating polymer network hydrogels. Acta Biomater. 7, 2384–2393.
DrugDeliv.Rev.112,24–34.doi:10.1016/j.addr.2016.07.009 doi:10.1016/j.actbio.2011.01.016
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 10 July2018|Volume6|Article99

--- Page 11 ---
Weberetal. HemocompatibilityofBlood-ContactingBiomaterials
Yau,J.W.,Teoh,H.,andVerma,S.(2015).Endothelialcellcontrolofthrombosis. Zimmermann,A.K.,Weber,N.,Aebert,H.,Ziemer,G.,andWendel,H.(2007).
BMCCardiovasc.Disord.15:130.doi:10.1186/s12872-015-0124-z Effectofbiopassiveandbioactivesurface-coatingsonthehemocompatibilityof
Zhang, J., Zhu, C., Fan, D., Ma, X., Mi, Y., and Xue, W. (2015). A two-step membraneoxygenators.J.Biomed.Mater.Res.BAppl.Biomater.80,433–439.
protocoltoremoveendotoxinsfromhuman-likecollagen.Sep.Sci.Technol.50, doi:10.1002/jbm.b.30614
993–1001.doi:10.1080/01496395.2014.978467
Zhang, L., Casey, B., Galanakis, D. K., Marmorat, C., Skoog, S., Vorvolakos, Conflict of Interest Statement: The authors declare that the research was
K.,etal.(2017).Theinfluenceofsurfacechemistryonadsorbedfibrinogen conductedintheabsenceofanycommercialorfinancialrelationshipsthatcould
conformation, orientation, fiber formation and platelet adhesion. Acta beconstruedasapotentialconflictofinterest.
Biomater.54,164–174.doi:10.1016/j.actbio.2017.03.002
Zhao, Y., Sun, X., Zhang, G., Trewyn, B. G., Slowing, I. I., and Lin, V. Copyright©2018Weber,Steinle,Golombek,Hann,Schlensak,WendelandAvci-
S. (2011). Interaction of mesoporous silica nanoparticles with human red Adali.Thisisanopen-accessarticledistributedunderthetermsoftheCreative
blood cell membranes: size and surface effects. ACS Nano 5, 1366–1375. CommonsAttributionLicense(CCBY).Theuse,distributionorreproductionin
doi:10.1021/nn103077k otherforumsispermitted,providedtheoriginalauthor(s)andthecopyrightowner(s)
Zhu,S.,Herbig,B.A.,Li,R.,Colace,T.V.,Muthard,R.W.,Neeves,K.B.,etal. arecreditedandthattheoriginalpublicationinthisjournaliscited,inaccordance
(2015).Inmicrofluidico:recreatinginvivohemodynamicsusingminiaturized withacceptedacademicpractice.Nouse,distributionorreproductionispermitted
devices.Biorheology52,303–318.doi:10.3233/BIR-15065 whichdoesnotcomplywiththeseterms.
FrontiersinBioengineeringandBiotechnology|www.frontiersin.org 11 July2018|Volume6|Article99

